These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


515 related items for PubMed ID: 18651646

  • 21. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R, Pakala R.
    EuroIntervention; 2009 Dec 15; 5 Suppl F():F36-42. PubMed ID: 22100674
    [Abstract] [Full Text] [Related]

  • 22. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries.
    Jabara R, Chronos N, Tondato F, Conway D, Molema W, Park K, Mabin T, King S, Robinson K.
    J Invasive Cardiol; 2006 Aug 15; 18(8):383-90. PubMed ID: 16877788
    [Abstract] [Full Text] [Related]

  • 23. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K, Gorycki B, Buszman PP, Jelonek M, Beaudry D, Lapointe JM, Guy LG, Abusamra M, Pająk J, Kinasz W, Wojakowski W, Leclerc G, Gil RJ, Buszman PE.
    Kardiol Pol; 2012 Aug 15; 70(7):703-11. PubMed ID: 22825946
    [Abstract] [Full Text] [Related]

  • 24. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
    Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):193-202. PubMed ID: 16814667
    [Abstract] [Full Text] [Related]

  • 25. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M, Farb A, Schreiber R, Terfera K, Arab A, Geist A, Haberstroh J, Wnendt S, Virmani R, Hehrlein C.
    Catheter Cardiovasc Interv; 2005 Jan 04; 64(1):85-90. PubMed ID: 15619311
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C.
    J Am Coll Cardiol; 2006 May 02; 47(9):1786-95. PubMed ID: 16682302
    [Abstract] [Full Text] [Related]

  • 34. The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
    Huang Y, Venkatraman SS, Boey FY, Umashankar PR, Mohanty M, Arumugam S.
    J Interv Cardiol; 2009 Oct 02; 22(5):466-78. PubMed ID: 19627432
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
    Radeleff B, Thierjung H, Stampfl U, Stampfl S, Lopez-Benitez R, Sommer C, Berger I, Richter GM.
    Cardiovasc Intervent Radiol; 2008 Oct 02; 31(5):971-80. PubMed ID: 18095019
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D, Billinger M, Meier P, Beslac O, Grossenbacher R, Hänni B, Hess OM.
    J Invasive Cardiol; 2008 Dec 02; 20(12):631-4. PubMed ID: 19057024
    [Abstract] [Full Text] [Related]

  • 40. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
    Nakazawa G, Finn AV, John MC, Kolodgie FD, Virmani R.
    Am J Cardiol; 2007 Oct 22; 100(8B):36M-44M. PubMed ID: 17950831
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.